Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: Development of immunologic and clinical abnormalities. A longitudinal study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • M. Melbye
  • R. J. Biggar
  • P. Ebbesen
  • C. Neuland
  • J. J. Goedert
  • V. Faber
  • I. Lorenzen
  • P. Skinhøj
  • R. C. Gallo
  • W. A. Blattner

The long-term seropositivity for human T-lymphotropic virus type III (HTLV-III) on T-lymphocyte subsets and health status were evaluated in longitudinal studies of 250 initially healthy homosexual men. The relative risk of having an inverted T-lymphocyte helper-to-suppressor ratio rose from 14.3-fold among short-term seropositive subjects (less than 19 months) to 46.9-fold among long-term seropositive subjects (greater than 29 months) in comparison with the risk among seronegative subjects. Overall, 91.7% of long-term seropositive men had inverted ratios compared with 12.9% of seronegative men. None of the seropositive men who developed an inverted ratio later reestablished a normal ratio. Both decreased T-helper cell number and percentage (p=0.003) were significantly correlated with duration of seropositivity. Among seropositive persons, lymphoadenopathy was a highly significantly short-term as well as long-term consequence, whereas diarrhea, oral thrush, and herpes zoster were correlated with long-term seropositivity. Overall, 50% of long-term seropositive men compared with 16% of seronegative men developed at least one of five clinical symptoms (p<0.003). We conclude that a high proportion of persons infected with HTLV-III will develop measurable immunologic and clinical abnormalities.

OriginalsprogEngelsk
TidsskriftAnnals of Internal Medicine
Vol/bind104
Udgave nummer4
Sider (fra-til)496-500
Antal sider5
ISSN0003-4819
DOI
StatusUdgivet - 1986

ID: 260893899